Scrapie is a transmissible neurodegenerative disease that appears to result from an accumulation in the brain of an abnormal protease-resistant isoform of prion protein (PrP) called PrPsc. Conversion of the normal, protease-sensitive form of PrP (PrP9) to protease-resistant forms like PrPsc has been demonstrated in a cell-free reaction composed largely of hamster PrPc and PrPsc. We now report studies of the species specificity of this cell-free reaction using mouse, hamster, and chimeric PrP molecules. Combinations of hamster PrPc with hamster PrPsc and mouse PrPc with mouse PrPsc resulted in the conversion of PrPc to proteaseresistant forms. Protease-resistant PrP species were also generated in the nonhomologous reaction of hamster PrPc with mouse PrPsc, but little conversion was observed in the reciprocal reaction. Glycosylation of the PrPc precursors was not required for species specificity in the conversion reaction.
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The relative conversion efficiencies correlated with the relative transmissibilities of these strains of scrapie between mice and hamsters. Conversion experiments performed with chimeric mouse/hamster PrPc precursors indicated that differences between PrPC and PrPsc at residues 139, 155, and 170 affected the conversion efficiency and the size of the resultant protease-resistant PrP species. We conclude that there is species specificity in the cell-free interactions that lead to the conversion of PrPc to protease-resistant forms. This specificity may be the molecular basis for the barriers to interspecies transmission of scrapie and other transmissible spongiform encephalopathies in vivo.
The transmissible spongiform encephalopathies (TSEs) include Creutzfeldt-Jakob disease, Gerstmann-Straussler disease, and kuru in humans, scrapie in sheep, mice, and hamsters, and bovine spongiform encephalopathy. These neurodegenerative diseases are characterized by the accumulation of abnormal protease-resistant forms of prion protein (PrP)-e.g., scrapie-associated PrP (PrPsc)-in diseased animals. PrPSc forms insoluble macromolecular aggregates and is partially resistant to proteinase K (PK) (1; 2), which removes -67 amino acid residues (6-7 kDa) from the N terminus (3, 4) . In contrast, the normal, nonpathogenic form, cellular PrP (PrPc), is soluble in mild detergents and easily degraded by PK (5, 6) . PrPc has been shown to be the precursor of PrPsc (7, 8) . No covalent difference has been detected between PrPc and PrPsc that explains their differences in aggregation properties and protease sensitivity (3, 9) . Although infectivity has not been separated from PrPsc (10, 11), the exact makeup of the infectious agent remains speculative.
One important phenomenon associated with TSE agents is the barrier to interspecies transmission that often exists in the form of complete resistance to transmission or an increased
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Cambridge, MA, January 9, 1995 (received for review incubation period between the time of infection and clinical disease. This "species barrier" varies depending on the species being infected and the specific strain of TSE agent involved. For instance, Chandler mouse scrapie can be transmitted to Syrian hamsters with an incubation period of -378 days but transmission into mice is faster ('120 days) (12, 13) . Conversely, the 263K hamster scrapie strain has a 60-day incubation period in Syrian hamsters but has not been successfully transmitted to mice (no clinical disease after 2 years) (14) . Of particular concern is whether or not various strains of TSEs in animals can be transmitted to humans. Epidemiological studies indicate that transmission from scrapie-infected sheep to humans does not occur. However, the recent epidemic of bovine spongiform encephalopathy in Great Britain has raised concern that this apparently new strain of TSE might be infectious to humans.
These concerns have highlighted the importance of understanding the basis for species barriers in the transmission of TSEs. Genetic studies have indicated that the PrP genotype strongly influences the host susceptibility of TSE agents from different species (15) (16) (17) . Other studies have indicated that compatibility between PrPc and PrPsc molecules is required for efficient PrPsc accumulation (18) (19) (20) (21) (22) . This compatibility requirement suggested that PrPsc and PrPc may interact during PrPsc formation as had been proposed earlier (3, 23, 24) . More recently, we obtained evidence that such an interaction is, in fact, sufficient for PrPsc formation by demonstrating that hamster PrPc can be converted to PK-resistant forms in a cell-free reaction with hamster PrPsc (25) . In the present study, we explore the species specificity of the cell-free PrPc conversion reaction using either hamster-or mouse-derived PrPSc in combination with mouse, hamster, and chimeric PrPc constructs to assess whether the TSE species barriers might be the result of incompatibilities in direct PrPc-PrPsc interactions.
MATERIALS AND METHODS
The mouse (Chandler strain) and hamster (263K strain) PrPsc used was isolated from scrapie-infected animal brains using a modification of the method of Bolton et al. (26) as described (27) normal hamster PrP (HaPrP) have been described (28) . Two mouse/hamster PrP chimeras, Mo/Ha 33 and Mo/Ha 40, were derived by utilizing the unique Nae I site within HaPrP and Mo-3F4 as described for Mo/Ha 40 (19) . Additional recombinants, Mo/Ha 66 and Mo/Ha 67, were derived by PCR mutagenesis using standard techniques.
Recombinant PrP molecules were expressed in normal mouse neuroblastoma (MNB) cells using the pSFF retroviral expression system as described (19, 28) . One of these lines, HPrP-D4, expresses HaPrP and has been described (25) . Cells expressing the other recombinant PrP molecules were derived by limiting dilution cloning of bulk cultures of MNB cells expressing recombinant PrP molecules according to published procedures (19, 28) .
The (29)]. In the case of MoPrP, which lacks the 3F4 epitope, R30, a rabbit polyclonal antiserum raised against PrP 89-103 was used (30) . The PrP antibody complexes were collected using protein A-Sepharose and eluted in either 3 or 7.5 M guanidine hydrochloride (Gdn.HCl) as described (25) .
To denature PrPsc, a suspension of 1 mg of PrPSc per ml in 3 M Gdn HCl was incubated 2-24 hr at 37°C. In the conversion reaction (25) The effect of glycosylation of MoPrPc on the species specificity of the conversion was tested using 35S-MoPrPc labeled in the presence of tunicamycin (32) , which prevents the Asn-linked glycosylation of proteins. This 25-kDa unglycosylated 35S-MoPrPc yielded three PK-resistant bands between 12 and 15 kDa (Fig. 1, lane 8) . In contrast, when the unglycosylated 35S-MoPrPc was incubated with HaPrPSc, little conversion was detected (Fig. 1, lane 7) . Thus, species-specific differences in the MoPrPc conversion were observed whether or not the MoPrPc precursor was glycosylated.
Effect of PrPsc Species on the Conversion of HaPrPC to PK-Resistant Forms. The species specificity of the conversion of HaPrPC to PK-resistant forms was tested by substituting MoPrPsc for HaPrPsc in the cell-free reaction. Two different constructs of 35S-HaPrPc, expressed with and without the glycophosphatidylinositol (GPI) anchor (25), were used. As shown in Fig. 2, 35S -labeled PK-resistant bands were generated from the incubation of either 35S-HaPrPc construct with MoPrPsc, but the profile of resistant bands generated was different than that generated by HaPrPSc. For instance, the most intense PK-resistant band resulting from the incubation of the HaPrPc construct with MoPrPSc was 18 kDa (lane 3) as opposed to 25 kDa with HaPrPSc (lane 2), indicating that an additional -7 kDa of the newly resistant 35S-HaPrPc molecule was cleaved by PK after incubation with MoPrPsc. Similar species-dependent differences were seen when the mostly unglycosylated GPI-HaPrPc was used (lanes 7 and 8).
To determine if the species specificity of the conversion reaction would persist under more denaturing conditions, the reaction was performed in 2 M Gdn-HCl (the optimum for the 35S-MoPrPc-MoPrPsc conversion in Fig. 1 ) instead of 0.75 M (Fig. 2) . The PrPSc species-dependent size differences of the PK-resistant 35S-labeled HaPrP conversion products were similar at both concentrations of Gdn-HCl. However, the higher Gdn HCl concentration greatly reduced the efficiency of the conversion with HaPrPSc (compare lanes 2 vs. 4 and 7 vs. 9), while it did not decrease the conversion with MoPrPsc (compare lanes 3 vs. 5 and 8 vs. 10). Thus, in addition to the species-specific differences in the sizes of the PK-resistant conversion products, there was also a difference in the Gdn-HCl sensitivity of the conversion reaction. Effect of Gdn-HCI Pretreatment of HaPrPc on the Species Specificity. In Fig. 2 , the 35S-HaPrPc used was pretreated with 3 M Gdn-HCl while the 35S-MoPrPc used in Fig. 1 was pretreated with 7.5 M. To test if the species-specific differences in the HaPrPc-HaPrPsc conversion reaction were sensitive to the extent of Gdn HCl pretreatment of HaPrPc, 35S-HaPrPc pretreated with 3 and 7.5 M Gdn HCl was directly compared. No difference in the 35S-PrP conversion products was observed (data not shown), providing evidence that the extent of denaturation of PrPc caused by these different Gdn-HCl pretreatments was not important in determining the species specificity of the conversion reactions with HaPrPSc and MoPrPsc.
PrP Sequences Affecting Species Specificity. To study what regions of the PrPc primary sequence influence the conversion to PK-resistant forms, we used various Mo/Ha PrPc chimeras (sequences in Fig. 3 and data in Fig. 4) in the conversion reaction with either MoPrPSc or HaPrPsc. These reactions were done at 1.25 M Gdn-HCl, which allows conversion by MoPrPsc or HaPrPsc but is not optimal for either reaction. All constructs yielded PK-resistant products after incubation with MoPrPsc, with some variation in the size of the major bands produced.
After incubation with HaPrPsc, only Mo/Ha 33, Mo/Ha 67, and HaPrPc yielded obvious PK-resistant products up to 32 kDa (Figs. 2 and 4) with a banding pattern typical of that seen when PrPs is treated with PK (30, 33) . HaPrPc (GPI-) converted with HaPrPsc, but to smaller bands because of the lack of a GPI anchor and less glycosylation. The constructs that significantly converted to PK-resistant forms with HaPrPSc all had the central segment (see Fig. 3 ) of HaPrP, which differs from the MoPrP sequence at residues 139, 155, and 170. Thus, these residues are important in determining the species specificity of the reactions of PrPc constructs with the HaPrPSc.
DISCUSSION
The precise nature of the infectious agent causing scrapie and other TSEs is uncertain. One proposal is that TSEs are transmitted solely by an abnormal isoform of a host proteini.e, PrPscP which converts the normal endogenous form of the protein, PrPc, to the pathogenic form (23, 24, (34) (35) (36) . This "protein-only" theory remains controversial and unproven, but our recent demonstration that PrPC can convert to PKresistant forms upon incubation with preexisting PrPsc in vitro provided evidence that a direct interaction between PrPSc and PrPc may be sufficient for propagation of the PrPSc molecules (25) . Nonetheless, the existence of species barriers and the adaptation of agent strains that occurs upon crossing species barriers encouraged investigators to argue that an agent with a mutable nucleic acid genome is responsible for transmission. However, in the present study, we have demonstrated species specificity in the reaction that converts PrPc to PK-resistant forms; this specificity in PrPc-PrPsc interactions could explain species barriers to scrapie transmission without invoking a nucleic acid genome for the infectious agent.
Our central biochemical observation is that PrPSc from scrapie-infected mice and hamsters induced the conversion of a single PrPc sequence to products with different PK sensitivities. One interpretation of these results is that the 35S-PrPc molecules adopt distinct conformations upon incubation with different PrPsc preparations. Distinct conformations would present unique cleavage sites to the enzyme, giving rise to variation in the PK-resistant bands detected. Different PrPSc aggregates could induce distinct conformations in a given PrPc through a seeded polymerization mechanism, for instance (25) . However, we cannot be certain that differences in PK resistance were solely the result of interactions with the different PrPSc molecules since some unidentified, speciesspecific component of the PrPsc preparations could conceivably have influenced PK resistance.
PK treatment of brain-derived PrPsc from scrapie-infected mice and hamsters usually reduces its mass -6-7 kDa. Similarly, PK treatment of the products of the cell-free incubation of HaPrPsc with either HaPrPc, HaPrPC (GPI-), Mo/Ha 67 PrPc, or Mo/Ha 33 PrPc generated labeled PrP species that were 6-7 kDa lower in molecular mass than the HaPrPC precursor molecule. In contrast to the 6-to 7-kDa molecular mass shift of the products of cell-free conversion by HaPrPsc, the cell-free reactions of the various 35S-PrPc constructs with If PrPSc alone is the transmissible agent in scrapie, then some species-specific properties of the molecule (e.g., amino acid sequence and conformation) must lead to species-specific responses of the host to PrPsc that modulate the course of disease following infection. Our present results provide evidence that there is species specificity in the direct interactions between PrPSc and PrPc that lead to the conversion of PrPc to PK-resistant forms. One possible mechanism is shown in Fig.   5 . When the conversion reaction was performed with HaPrPSc and 35S-MoPrPc, little conversion to labeled PK-resistant products was observed. This result correlates with the lack of transmission of 263K hamster scrapie to mice (14) . In contrast, when 35S-HaPrPc was incubated with either MoPrPsc or HaPrPsc, similar amounts of labeled PK-resistant products were generated. This result correlates with the fact that Chandler strain mouse scrapie can be transmitted to hamsters, albeit with a longer incubation time than when transmitted into mice (12, 13) . The longer incubation time in hamsters may relate to our observation that the PK-resistant 35S-HaPrP bands resulting from the cell-free incubation with MoPrPSc were smaller than those generated by HaPrPSc. These smaller conversion products might be less pathogenic if generated in a hamster in vivo or may be less able to convert more HaPrPc to HaPrPSc than is 263K HaPrPSc. These results suggest that an important molecular basis for species specificity in the transmission of scrapie may be the compatibility between the foreign PrPsc, acting as the infectious agent or a component of the agent, and the host PrPc.
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